Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The latest updates on our research and how it is improving people’s lives.

Training course in Ethiopia for treating older children with clubfoot

Main

A training course on Principles of Management for Delayed Presenting Clubfoot (DPC) took place 11-12th December 2023 at CURE Children’s Hospital of Ethiopia, Addis Ababa.

New reporting guideline will provide transparency in consensus research

Main

Published in PLOS, the new guideline will help the scientific community to write complete and transparent research reports involving consensus methods.

NDORMS hosts a visit from Taipei Medical University researchers

Main

NDORMS welcomed a delegation of medical researchers from Taipei Medical University this week to exchange research ideas and for potential future collaborations.

Lymph node research pioneers' new approach to vaccine design for the most vulnerable

Main

The Oxford Experimental Medicine Clinical Research Facility (EMCRF) at NDORMS has received its first volunteers as part of the LEGACY03 trial to improve vaccine design for different age groups.

COVID-19 vaccines found effective in reducing long COVID symptoms

Main

A recent study has revealed the effectiveness of COVID-19 vaccines in preventing long COVID.

Caroline Morrell awarded an MRC Fellowship

Main

A DPhil candidate at NDORMS, Caroline received the MRC Clinical Research Training Fellowship that has enabled her to further her research into head and neck cancer.

Patients can interrupt treatment of immune-supressing medicines for two-weeks in order to boost immunity provided by COVID-19 booster vaccine, finds major study

Main

A major clinical trial, led by the University of Nottigham and managed by the Oxford Clinical trials Research Unit (OCTRU), has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.

NDORMS researchers awarded funding to spark new avenues of research

Main

Four researchers at NDORMS have been awarded a Research Ignition Award, as part of an initiative by the Kennedy Trust for Rheumatology to stimulate new and ambitious avenues of research.

Professor Chris Lavy awarded honorary fellowship from the College of Surgeons of East, Central and Southern Africa

Main

Professor Chris Lavy has been awarded an honorary fellowship by the College of Surgeons of East Central and Southern Africa (COSECSA).

Ben Dean awarded ORUK funding

Main

Senior Research Fellow Ben Dean has been awarded funding by Orthopaedic Research UK (ORUK) for his work on wrist injuries.

Kennedy Trust gift to help drive forward research into inflammatory and musculoskeletal diseases at Oxford

Main

Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.

Tom Hosack awarded an MRC Fellowship

Main

A DPhil candidate at NDORMS, Tom Hosack received the MRC Clinical Research Training Fellowship to further his research into tissue tropism in PD-1 therapy in immune-mediated inflammatory diseases.

New discovery furthers our understanding of how critical immune cells are controlled during an infection

Main

A recent publication from Audrey Gérard’s lab looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection.

Putting Multiple Myeloma onto a new course

Main

The annual Oxford Myeloma Workshop brings together experts in myeloma research, clinical care, patient advocates and industry representatives, to help international efforts to improve patient lives affected by multiple myeloma. Multiple myeloma is the second most common among all blood cancers, is currently incurable and puts massive strains on patient quality of life with a significantly higher proportion (10 fold) share in health care costs.

Study reveals inequalities in access to shoulder replacement surgery

Main

As demand for shoulder replacement surgery grows, a new study finds that up to 1 in 6 patients are having to travel to a different region for surgery, and exposes a year on year increase in the risk of serious adverse events after surgery that require admission to hospital.

First UK spine fracture patients identified by NHS-X and Nanox.AI Artificial Intelligence research study

Main

The NHS ADOPT study has now begun to automatically identify patients with vertebral fracture, by using Nanox.AI an Artificial Intelligence (AI) programme to review thousands of hospital computed tomography (CT) scans. The patients are now being fast-tracked for bone health assessment by an NHS osteoporosis team.

NDORMS launches new translational unit to further critical research into multiple myeloma

Main

The Oxford Translational Myeloma Centre (OTMC) will be a collective force of research, outreach and patient care that will transform treatment opportunities for multiple myeloma cancer patients.

Daniele Cotton wins St Edmund Hall’s Ex Aula Prize

Main

Congratulations to Daniele Cotton winner of St Edmund Hall’s graduate research journal prize for his article ‘Jailbreak – Preventing Metastatic Cancer.’

How to build a cellular map of the musculoskeletal system

Main

A single-cell resolution atlas of the human musculoskeletal system could be transformative to understanding and treating conditions including arthritis, cancer and fractures.

New research endoscopy service launches today

Main

The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at NDORMS and across the University of Oxford.

Load More